29
Apr
A recent study funded by the Centers for Disease Control and Prevention (CDC) suggests that newly approved vaccines for respiratory syncytial virus (RSV) could reduce the severity of the disease, similar to how COVID-19 vaccines lessen the severity of SARS-CoV-2 infections. The study compared disease severity in patients who received…